Biogen stock up following good news for compeititor, Genzyme
June 28, 2013 at 12:45 PM EDT
On Friday, some good news for a Genzyme Corp., competitor of Biogen Idec (Nasdaq: BIIB) in the multiple sclerosis market, also became good news for Biogen, boosting it’s stock price more than 5 percent by mid-day...
